Steven Glazer joins Hervolution as Medical Advisor

Steven Glazer has many years of international experience in healthcare and biotechnology. He has held a number of senior positions within pharmaceutical and bioengineering companies in Europe and the US, including Novo Nordisk, Zealand Pharma, BioInvent International and  Hansa Medical, and has gained deep knowledge of pharmaceutical development involving medical and regulatory planning. Steven’s current assignments are:  Board member of Immunicum; Partner in Ventac Partners;  and owner of consultancy company Glazer Consulting ApS.

Related news

SIRION Biotech Licenses Adenovirus Technology to Danish Startup, Hervolution for its Novel Immunotherapy Design Targeting Endogenous Retrovirus (ERV)